Advertisement

The synthesis and characterization of glutathione-modified superparamagnetic iron oxide nanoparticles and their distribution in rat brains after injection in substantia nigra

  • Guihua Han
  • Baolin ZhangEmail author
  • Hao Zhang
  • Dong Han
  • Jie TanEmail author
  • Boning YangEmail author
Biomaterials Synthesis and Characterization Original Research
  • 91 Downloads
Part of the following topical collections:
  1. Biomaterials Synthesis and Characterization

Abstract

Glutathione-modified superparamagnetic iron oxide nanoparticles (GSH-SPIONs) were prepared by conjugating glutathione (GSH) on the surface of the PEG (Polyethylene glycol)/PEI (polyethyleneimine)-SPIONs which were synthesized by thermal decomposition method. Thermogravimetric analysis showed that the mass fraction of GSH on the surface of SPIONs was 30.64 wt%. GSH-SPIONs in PBS were injected into the substantia nigra of rat brains. The subcellular distributions of the nanoparticles in the brains was examined by the transmission electron microscope (TEM). A remarkable amount of GSH-SPIONs were found in vesicles inside cell bodies and axons, and in mitochondria. TEM pictures show that GSH-SPIONs enter the neuronal cells by endocytosis and travel through axoplasmic transport. GSH-SPIONs have great potential as drug delivery agents in the brain to treat diseases or study brain function via mitochondria-targeting way or axoplasmic transport way.

Notes

Acknowledgements

This work was financially supported by the National Natural Science Foundation of China (No. 51562007).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

10856_2018_6209_MOESM1_ESM.docx (566 kb)
Supplementary Information

References

  1. 1.
    Abbasi Pour S, Shaterian HR. Design and characterization of lisinopril-loaded superparamagnetic nanoparticles as a new contrast agent for in vitro, in vivo MRI imaging, diagnose the tumors and drug delivery system. J Mater Sci Mater Med. 2017;28:91.CrossRefGoogle Scholar
  2. 2.
    Islam MS, Haque P, Rashid TU, Khan MN, Mallik AK, Khan MN, et al. Core-shell drug carrier from folate conjugated chitosan obtained from prawn shell for targeted doxorubicin delivery. J Mater Sci Mater Med. 2017;28:55.CrossRefGoogle Scholar
  3. 3.
    Huang Y, Mao K, Zhang B, Zhao Y. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics. Mater Sci Eng C Mater Biol Appl. 2017;70:763–71.CrossRefGoogle Scholar
  4. 4.
    Singh N, Jenkins GJ, Asadi R, Doak SH. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev. 2010;1:1–15.CrossRefGoogle Scholar
  5. 5.
    Lee CM, Jeong HJ, Kim SL, Kim EM, Kim DW, Lim ST, et al. SPION-loaded chitosan-linoleic acid nanoparticles to target hepatocytes. Int J Pharm. 2009;371:163–9.CrossRefGoogle Scholar
  6. 6.
    Nicolas J, Mura S, Brambilla D, Mackiewicz N, Couvreur P. Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery. Chem Soc Rev. 2013;42:1147–235.CrossRefGoogle Scholar
  7. 7.
    Xiong F, Huang S, Gu N. Magnetic nanoparticles: recent developments in drug delivery system. Drug Dev Ind Pharm. 2018;44:697–706.CrossRefGoogle Scholar
  8. 8.
    Xu HL, Mao KL, Huang YP, Yang JJ, Xu J, Chen PP, et al. Glioma-targeted superparamagnetic iron oxide nanoparticles as drug-carrying vehicles for theranostic effects. Nanoscale. 2016;8:14222–36.CrossRefGoogle Scholar
  9. 9.
    Hudson R. Coupling the magnetic and heat dissipative properties of Fe3O4 particles to enable applications in catalysis, drug delivery, tissue destruction and remote biological interfacing. RSC Adv. 2016;6:4262–70.CrossRefGoogle Scholar
  10. 10.
    Xie J, Gu N, Zhang Y. Controlled synthesis and surface modification of magnetic nanoparticles with high performance for cancer theranostics combining targeted MR imaging and hyperthermia. In: Dai Z, editor. Advances in nanotheranostics II: cancer theranostic nanomedicine. Singapore: Springer Singapore; 2016, 39–73.Google Scholar
  11. 11.
    Lachowicz D, Szpak A, Malek-Zietek KE, Kepczynski M, Muller RN, Laurent S, et al. Biocompatible and fluorescent superparamagnetic iron oxide nanoparticles with superior magnetic properties coated with charged polysaccharide derivatives. Colloids Surf B Biointerfaces. 2017;150:402–7.CrossRefGoogle Scholar
  12. 12.
    Luchini A, Heenan RK, Paduano L, Vitiello G. Functionalized SPIONs: the surfactant nature modulates the self-assembly and cluster formation. Phys Chem Chem Phys. 2016;18:18441–9.CrossRefGoogle Scholar
  13. 13.
    Luchini A, Vitiello G, Rossi F, Ruiz De Ballesteros O, Radulescu A, D’Errico G, et al. Developing functionalized Fe3O4-Au nanoparticles: a physico-chemical insight. Phys Chem Chem Phys. 2015;17:6087–97.CrossRefGoogle Scholar
  14. 14.
    Chen R, Romero G, Christiansen MG, Mohr A, Anikeeva P. Wireless magnetothermal deep brain stimulation. Science. 2015;347:1477–80.CrossRefGoogle Scholar
  15. 15.
    Stanley SA, Gagner JE, Damanpour S, Yoshida M, Dordick JS, Friedman JM. Radio-wave heating of iron oxide nanoparticles can regulate plasma glucose in mice. Science. 2012;336:604–8.CrossRefGoogle Scholar
  16. 16.
    Liu Y, Li J, Xu K, Gu J, Huang L, Zhang L et al. Characterization of superparamagnetic iron oxide nanoparticle-induced apoptosis in PC12 cells and mouse hippocampus and striatum. Toxicol Lett. 2018;292:151–61.CrossRefGoogle Scholar
  17. 17.
    Luchini A, Gerelli Y, Fragneto G, Nylander T, Palsson GK, Appavou MS, et al. Neutron Reflectometry reveals the interaction between functionalized SPIONs and the surface of lipid bilayers. Colloids Surf B Biointerfaces. 2017;151:76–87.CrossRefGoogle Scholar
  18. 18.
    Zhao F, Zhao Y, Liu Y, Chang X, Chen C, Zhao Y. Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. Small. 2011;7:1322–37.CrossRefGoogle Scholar
  19. 19.
    Santos MC, Seabra AB, Pelegrino MT, Haddad PS. Synthesis, characterization and cytotoxicity of glutathione- and PEG-glutathione-superparamagnetic iron oxide nanoparticles for nitric oxide delivery. Appl Surf Sci. 2016;367:26–35.CrossRefGoogle Scholar
  20. 20.
    Rahantaniaina MS, Li S, Chatel-Innocenti G, Tuzet A, Mhamdi A, Vanacker H, et al. Glutathione oxidation in response to intracellular H2O2: key but overlapping roles for dehydroascorbate reductases. Plant Signal Behav. 2017;12:e1356531.CrossRefGoogle Scholar
  21. 21.
    He C, Jiang S, Jin H, Chen S, Lin G, Yao H, et al. Mitochondrial electron transport chain identified as a novel molecular target of SPIO nanoparticles mediated cancer-specific cytotoxicity. Biomaterials. 2016;83:102–14.CrossRefGoogle Scholar
  22. 22.
    Yu M, Zhou C, Liu J, Hankins JD, Zheng J. Luminescent gold nanoparticles with pH-dependent membrane adsorption. J Am Chem Soc. 2011;133:11014–7.CrossRefGoogle Scholar
  23. 23.
    Vinluan RD 3rd, Liu J, Zhou C, Yu M, Yang S, Kumar A, et al. Glutathione-coated luminescent gold nanoparticles: a surface ligand for minimizing serum protein adsorption. ACS Appl Mater Interfaces. 2014;6:11829–33.CrossRefGoogle Scholar
  24. 24.
    Yoffe S, Leshuk T, Everett P, Gu F. Superparamagnetic iron oxide nanoparticles (SPIONs): synthesis and surface modification techniques for use with MRI and other biomedical applications. Curr Pharm Des. 2013;19:493–509.CrossRefGoogle Scholar
  25. 25.
    Zhang Y, Kohler N, Zhang M. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials. 2002;23:1553–61.CrossRefGoogle Scholar
  26. 26.
    Muthiah M, Park IK, Cho CS. Surface modification of iron oxide nanoparticles by biocompatible polymers for tissue imaging and targeting. Biotechnol Adv. 2013;31:1224–36.CrossRefGoogle Scholar
  27. 27.
    Zhao F, Zhang B, Feng L. Preparation and magnetic properties of magnetite nanoparticles. Mater Lett. 2012;68:112–4.CrossRefGoogle Scholar
  28. 28.
    Gogoi M, Deb P, Vasan G, Keil P, Kostka A, Erbe A. Direct monophasic replacement of fatty acid by DMSA on SPION surface. Appl Surf Sci. 2012;258:9685–91.CrossRefGoogle Scholar
  29. 29.
    Xu P, Shen Z, Zhang B, Wang J, Wu R. Synthesis and characterization of superparamagnetic iron oxide nanoparticles as calcium-responsive MRI contrast agents. Appl Surf Sci. 2016;389:560–6.CrossRefGoogle Scholar
  30. 30.
    Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W. Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol. 2004;16:437–45.CrossRefGoogle Scholar
  31. 31.
    Brown A. Axonal transport of membranous and nonmembranous cargoes: a unified perspective. J Cell Biol. 2003;160:817–21.CrossRefGoogle Scholar
  32. 32.
    Xu S, Olenyuk BZ, Okamoto CT, Hamm-Alvarez SF. Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances. Adv Drug Deliv Rev. 2013;65:121–38.CrossRefGoogle Scholar
  33. 33.
    Su L, Zhang B, Huang Y, Zhang H, Xu Q, Tan J. Superparamagnetic iron oxide nanoparticles modified with dimyristoylphosphatidylcholine and their distribution in the brain after injection in the rat substantia nigra. Mater Sci Eng C Mater Biol Appl. 2017;81:400–6.CrossRefGoogle Scholar
  34. 34.
    Su L, Zhang B, Huang Y, Fan Z, Zhao Y. Enhanced cellular uptake of iron oxide nanoparticles modified with 1,2-dimyristoyl-sn-glycero-3-phosphocholine. RSC Adv. 2017;7:38001–7.CrossRefGoogle Scholar
  35. 35.
    Kim Y-K, Zhang M, Lu J-J, Xu F, Chen B-A, Xing L, et al. PK11195-chitosan-graft-polyethylenimine-modified SPION as a mitochondria-targeting gene carrier. J Drug Target. 2016;24:457–67.CrossRefGoogle Scholar
  36. 36.
    Chakraborty A, Jana NR. Design and synthesis of triphenylphosphonium functionalized nanoparticle probe for mitochondria targeting and imaging. J Phys Chem C. 2015;119:2888–95.CrossRefGoogle Scholar
  37. 37.
    Ghasemi A, Jafari S, saeidi J, Mohtashami M, Salehi I. Synthesis and characterization of polyglycerol coated superparamagnetic iron oxide nanoparticles and cytotoxicity evaluation on normal human cell lines. Colloids Surf A Physicochem Eng Asp. 2018;551:128–36.CrossRefGoogle Scholar
  38. 38.
    Milane L, Trivedi M, Singh A, Talekar M, Amiji M. Mitochondrial biology, targets, and drug delivery. J Control Release. 2015;207:40–58.CrossRefGoogle Scholar
  39. 39.
    Wang B, Feng WY, Wang M, Shi JW, Zhang F, Ouyang H, et al. Transport of intranasally instilled fine Fe2O3 particles into the brain: micro-distribution, chemical states, and histopathological observation. Biol Trace Elem Res. 2007;118:233–43.CrossRefGoogle Scholar
  40. 40.
    Lasek RJ, Garner JA, Brady ST. Axonal transport of the cytoplasmic matrix. J Cell Biol. 1984;99:212–21.CrossRefGoogle Scholar
  41. 41.
    Jinlu Z, Qing C, Junpeng Z, Mingfu L, Yilin S, Bing W, et al. Ultrastructure of the nervous system. 1st edn. Beijing. 2011; Peking Union Medical College Press.Google Scholar
  42. 42.
    Davis BM, Tian K, Pahlitzsch M, Brenton J, Ravindran N, Butt G, et al. Topical Coenzyme Q10 demonstrates mitochondrial-mediated neuroprotection in a rodent model of ocular hypertension. Mitochondrion. 2017;36:114–23.CrossRefGoogle Scholar
  43. 43.
    Li WQ, Wang Z, Hao S, He H, Wan Y, Zhu C, et al. Mitochondria-targeting polydopamine nanoparticles to deliver doxorubicin for overcoming drug resistance. ACS Appl Mater Interfaces. 2017;9:16793–802.CrossRefGoogle Scholar
  44. 44.
    Castle MJ, Gershenson ZT, Giles AR, Holzbaur EL, Wolfe JH. Adeno-associated virus serotypes 1, 8, and 9 share conserved mechanisms for anterograde and retrograde axonal transport. Hum Gene Ther. 2014;25:705–20.CrossRefGoogle Scholar
  45. 45.
    Salegio EA, Streeter H, Dube N, Hadaczek P, Samaranch L, Kells AP, et al. Distribution of nanoparticles throughout the cerebral cortex of rodents and non-human primates: Implications for gene and drug therapy. Front Neuroanat. 2014;8:9.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Key Laboratory of Nonferrous and Materials Processing Technology, Ministry of Education; Guangxi Key Laboratory of Optical and Electronic Materials and Devices; College of Materials Science and EngineeringGuilin University of TechnologyGuilinChina
  2. 2.Guangxi Key Laboratory of Brain and Cognitive NeuroscienceGuilin Medical UniversityGuilinChina
  3. 3.Guangxi Collaborative Innovation Center for Biomedicine and Department of Human AnatomyGuangxi Medical UniversityNanningChina

Personalised recommendations